Its use is best avoided in the management of hypertensive crises - Ashley and Brooke Barlow PharmDs
image by: Yoursy Yoursy
Hydralazine is much like rolling the dice on blood pressure management. You do not know when the blood pressure will change or what level to expect it to drop. Following its administration, hydralazine has a latent period ranging from five to 15 minutes before onset of action, and after onset it can cause an abrupt fall in blood pressure lasting up to 12 hours...
Perhaps the perception is that hydralazine is a benign medication and that one dose of hydralazine can't possibly be that harmful. Sadly, given its long half-life, adverse effects may not be recognized or connected to hydralazine if they occur hours later, prompting the clinician to make poor reactionary decisions.
Hydralazine, a potent vasodilator, is used throughout the United States as an intravenous medication to lower blood pressure, and it is often used off-label for hypertensive emergencies though it has little evidence of improved outcomes. Many issues with hydralazine should raise eyebrows among emergency physicians.
Initiate therapy in gradually increasing dosages; adjust according to individual response. Start with 10 mg four times daily for the first 2 to 4 days, increase to 25 mg four times daily for the balance of the first week.
It is not a first-choice drug, but it can be helpful for people who have high blood pressure and other first-choice drugs are not working.
Hydralazine exerts a preferential effect on arterioles compared with veins. The resulting changes are decreased peripheral resistance; decreased blood pressure; and reflexively increased heart rate, stroke volume, and CO.
In current practice, oral hydralazine is used in essential hypertension refractory to other therapeutic agents. Studies comparing its effects as an add-on medication to multidrug treatment for hypertension have proved effective but not as efficacious as other multi-modal first-line therapies (calcium channel blockers, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, thiazides).
Your Path to Meaningful Connections in the World of Health and Medicine
Connect, Collaborate, and Engage!
Coming Soon - Stitches, the innovative chat app from the creators of HWN. Join meaningful conversations on health and medical topics. Share text, images, and videos seamlessly. Connect directly within HWN's topic pages and articles.